Paxil 30mg Tablets

Manufacturer APOTEX Active Ingredient Paroxetine Tablets(pa ROKS e teen) Pronunciation pa ROKS e teen
WARNING: Drugs like this one have raised the chance of suicidal thoughts or actions in children and young adults. The risk may be greater in people who have had these thoughts or actions in the past. All people who take this drug need to be watched closely. Call the doctor right away if signs like depression, nervousness, restlessness, grouchiness, panic attacks, or changes in mood or actions are new or worse. Call the doctor right away if any thoughts or actions of suicide occur.This drug is not approved for use in children. Talk with the doctor. @ COMMON USES: It is used to treat depression.It is used to treat obsessive-compulsive problems.It is used to treat panic attacks.It is used to treat anxiety.It is used to treat post-traumatic stress. It may be given to you for other reasons. Talk with the doctor.
đŸˇī¸
Drug Class
Antidepressant
đŸ§Ŧ
Pharmacologic Class
Selective Serotonin Reuptake Inhibitor (SSRI)
🤰
Pregnancy Category
Category D
✅
FDA Approved
Dec 1992
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Paroxetine is a medication called an antidepressant. It works by helping to restore the balance of a natural substance (serotonin) in the brain. This can help improve mood, sleep, appetite, and energy level, and decrease anxiety and panic attacks. It is used to treat depression, anxiety disorders, obsessive-compulsive disorder, panic disorder, post-traumatic stress disorder, and premenstrual dysphoric disorder.
📋

How to Use This Medicine

Taking Your Medication

To get the most benefit from your medication, follow your doctor's instructions carefully. Read all the information provided with your prescription and follow the instructions closely. You can take this medication with or without food. Continue taking your medication as directed by your doctor or healthcare provider, even if you start to feel well.

Some brands of this medication must be swallowed whole, so be sure to check with your doctor or pharmacist if you're unsure about your specific brand. Unless your doctor advises otherwise, take your medication in the morning.

Storing and Disposing of Your Medication

Store your medication at room temperature in a dry place, away from the bathroom. Keep all medications in a safe location, out of the reach of children and pets. Dispose of any unused or expired medication properly. Do not flush medication down the toilet or pour it down the drain unless instructed to do so by your pharmacist. If you have questions about disposing of your medication, ask your pharmacist. You may also want to check if there are any drug take-back programs in your area.

Missing a Dose

If you miss a dose, take it as soon as you remember. However, if it's close to the time for your next dose, skip the missed dose and return to your regular schedule. Do not take two doses at the same time or take extra doses to make up for a missed one.
💡

Lifestyle & Tips

  • Take paroxetine once daily, usually in the morning, with or without food. Swallow tablets whole; do not crush, chew, or break them.
  • Do not stop taking paroxetine suddenly without talking to your doctor, as this can cause withdrawal symptoms (e.g., dizziness, numbness, tingling, agitation, anxiety, confusion, headache, nausea, sweating, tremor, electric shock sensations). Your doctor will likely decrease your dose gradually.
  • Avoid alcohol while taking paroxetine, as it can worsen side effects like drowsiness and dizziness.
  • Be cautious when driving or operating machinery until you know how paroxetine affects you, as it may cause dizziness or drowsiness.
  • Inform your doctor or dentist that you are taking paroxetine before any surgery or dental procedures.
  • Report any unusual bleeding or bruising to your doctor immediately.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: For Major Depressive Disorder (MDD): 20 mg once daily, usually in the morning. For Obsessive-Compulsive Disorder (OCD): 40 mg once daily. For Panic Disorder: 40 mg once daily. For Social Anxiety Disorder: 20 mg once daily. For Generalized Anxiety Disorder (GAD): 20 mg once daily. For Post-Traumatic Stress Disorder (PTSD): 20 mg once daily. For Premenstrual Dysphoric Disorder (PMDD): 12.5 mg (controlled-release) or 25 mg (controlled-release) once daily.
Dose Range: 10 - 60 mg

Condition-Specific Dosing:

MDD: Initial: 20 mg/day. Titrate by 10 mg/day at weekly intervals to max 50 mg/day (immediate-release) or 62.5 mg/day (controlled-release).
OCD: Initial: 20 mg/day. Titrate by 10 mg/day at weekly intervals to max 60 mg/day (immediate-release).
Panic Disorder: Initial: 10 mg/day. Titrate by 10 mg/day at weekly intervals to max 60 mg/day (immediate-release).
Social Anxiety Disorder: Initial: 20 mg/day. Titrate by 10 mg/day at weekly intervals to max 50 mg/day (immediate-release).
GAD: Initial: 20 mg/day. Titrate by 10 mg/day at weekly intervals to max 50 mg/day (immediate-release).
PTSD: Initial: 20 mg/day. Titrate by 10 mg/day at weekly intervals to max 50 mg/day (immediate-release).
PMDD: Initial: 12.5 mg (controlled-release) or 25 mg (controlled-release) once daily. May increase to 25 mg (controlled-release) or 50 mg (controlled-release) once daily.
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established for MDD due to increased risk of suicidality. For OCD (7-17 years): Initial 10 mg/day, may increase by 10 mg/day at weekly intervals to max 50 mg/day.
Adolescent: Not established for MDD due to increased risk of suicidality. For OCD (7-17 years): Initial 10 mg/day, may increase by 10 mg/day at weekly intervals to max 50 mg/day.
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: No adjustment needed.
Moderate: Initial dose 10 mg/day (immediate-release) or 12.5 mg/day (controlled-release). Max 40 mg/day (immediate-release) or 50 mg/day (controlled-release).
Severe: Initial dose 10 mg/day (immediate-release) or 12.5 mg/day (controlled-release). Max 40 mg/day (immediate-release) or 50 mg/day (controlled-release).
Dialysis: Considerations: Paroxetine is highly protein-bound and not effectively removed by dialysis. Follow severe renal impairment guidelines.

Hepatic Impairment:

Mild: Initial dose 10 mg/day (immediate-release) or 12.5 mg/day (controlled-release). Max 40 mg/day (immediate-release) or 50 mg/day (controlled-release).
Moderate: Initial dose 10 mg/day (immediate-release) or 12.5 mg/day (controlled-release). Max 40 mg/day (immediate-release) or 50 mg/day (controlled-release).
Severe: Initial dose 10 mg/day (immediate-release) or 12.5 mg/day (controlled-release). Max 40 mg/day (immediate-release) or 50 mg/day (controlled-release).

Pharmacology

đŸ”Ŧ

Mechanism of Action

Paroxetine is a potent and highly selective inhibitor of serotonin (5-hydroxytryptamine; 5-HT) reuptake in the central nervous system (CNS). It has weak effects on norepinephrine and dopamine neuronal reuptake. The antidepressant and anxiolytic effects are presumed to be related to its potentiation of serotonergic activity in the CNS resulting from this inhibition.
📊

Pharmacokinetics

Absorption:

Bioavailability: Approximately 60-70% (variable due to first-pass metabolism)
Tmax: Immediate-release: 5.2 hours; Controlled-release: 6-10 hours
FoodEffect: Food does not significantly affect absorption, but may decrease Cmax and increase Tmax slightly. Can be taken with or without food.

Distribution:

Vd: Approximately 2.8 L/kg
ProteinBinding: Approximately 95% (primarily to plasma proteins)
CnssPenetration: Yes

Elimination:

HalfLife: Approximately 21 hours (range 10-24 hours)
Clearance: Variable due to saturable metabolism
ExcretionRoute: Approximately 64% via urine (2% as unchanged drug, 62% as metabolites); 36% via feces (30% as metabolites, 6% as unchanged drug)
Unchanged: Approximately 2% (urine), 6% (feces)
âąī¸

Pharmacodynamics

OnsetOfAction: Antidepressant effects typically begin within 2-4 weeks; anxiolytic effects may be seen earlier.
PeakEffect: Full therapeutic effect may take 4-6 weeks.
DurationOfAction: Due to its half-life, effects persist for approximately 24 hours, allowing once-daily dosing.

Safety & Warnings

âš ī¸

BLACK BOX WARNING

Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of Major Depressive Disorder (MDD) and other psychiatric disorders. Anyone considering the use of paroxetine or any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need. Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24; there was a reduction in risk with antidepressants compared to placebo in adults aged 65 and older. Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide. Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior. Families and caregivers should be advised of the need for close observation and communication with the prescriber. Paroxetine is not approved for use in pediatric patients except for Obsessive Compulsive Disorder (OCD) in patients 7-17 years of age.
âš ī¸

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention immediately:

Signs of an allergic reaction: rash, hives, itching, red, swollen, blistered, or peeling skin (with or without fever), wheezing, tightness in the chest or throat, trouble breathing, swallowing, or talking, unusual hoarseness, or swelling of the mouth, face, lips, tongue, or throat
Signs of low sodium levels: headache, difficulty focusing, memory problems, confusion, weakness, seizures, or changes in balance
Signs of infection: fever, chills, severe sore throat, ear or sinus pain, cough, increased or discolored sputum, painful urination, mouth sores, or a wound that won't heal
Signs of bleeding: vomiting or coughing up blood, coffee ground-like vomit, blood in the urine, black, red, or tarry stools, gum bleeding, abnormal vaginal bleeding, unexplained bruises or bruises that get bigger, or uncontrollable bleeding
Severe dizziness or fainting
Bone pain
Seizures
Significant weight loss
Abnormal burning, numbness, or tingling sensations
Painful or prolonged erections (lasting more than 4 hours)
Sexual problems, such as decreased libido, difficulty having an orgasm, ejaculation problems, or erectile dysfunction (talk to your doctor if you have concerns)

Serotonin Syndrome: A Potentially Life-Threatening Condition

There is a risk of developing serotonin syndrome, a severe and potentially deadly condition, especially when taking certain other medications. Seek medical help immediately if you experience:

Agitation
Changes in balance
Confusion
Hallucinations
Fever
Fast or abnormal heartbeat
Flushing
Muscle twitching or stiffness
Seizures
Shivering or shaking
Excessive sweating
Severe diarrhea, stomach upset, or vomiting
Severe headache

Other Possible Side Effects

Like all medications, this drug can cause side effects. While many people may not experience any side effects or only minor ones, it's essential to discuss any concerns with your doctor. If you experience any of the following side effects, contact your doctor or seek medical attention if they bother you or persist:

Dizziness, drowsiness, fatigue, or weakness
Nervousness or excitability
Headache
Constipation, diarrhea, stomach pain, nausea, vomiting, or decreased appetite
Gas
Dry mouth
Sleep disturbances
Shakiness
Yawning
Back pain
* Sweating

Reporting Side Effects

If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Worsening depression or suicidal thoughts/behavior, especially at the beginning of treatment or after a dose change.
  • Symptoms of serotonin syndrome: agitation, hallucinations, confusion, fast heartbeat, fever, sweating, shivering, muscle stiffness or twitching, loss of coordination, nausea, vomiting, diarrhea.
  • Symptoms of an allergic reaction: rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, trouble breathing.
  • New or worsening anxiety, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia (restlessness), hypomania, or mania.
  • Eye pain, changes in vision, or swelling/redness in or around the eye (may indicate acute angle-closure glaucoma).
  • Unusual bleeding or bruising.
  • Seizures.
  • Symptoms of low sodium (hyponatremia): headache, confusion, weakness, unsteadiness, memory problems.
📋

Before Using This Medicine

Before taking this medication, it is essential to inform your doctor about the following:

Any allergies you have, including allergies to this drug, its components, or other substances, such as foods or medications. Be sure to describe the symptoms you experienced as a result of the allergy.
If you have been diagnosed with narrow-angle glaucoma.
If you are currently taking or have recently taken any of the following medications: Linezolid, methylene blue, pimozide, or thioridazine.
If you have taken any medications for depression or Parkinson's disease within the last 14 days, including isocarboxazid, phenelzine, tranylcypromine, selegiline, or rasagiline, as this may increase the risk of very high blood pressure.

Please note that this is not an exhaustive list of all potential interactions between this medication and other substances. It is crucial to discuss all of your medications, including prescription and over-the-counter drugs, natural products, and vitamins, with your doctor and pharmacist to ensure safe use. Do not initiate, discontinue, or modify the dosage of any medication without first consulting your doctor to confirm that it is safe to do so in conjunction with this medication.
âš ī¸

Precautions & Cautions

Important Warnings and Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication.

Caution with Daily Activities
Until you know how this medication affects you, avoid driving and other activities that require alertness.

Stopping the Medication
Do not stop taking this medication abruptly without consulting your doctor, as this may increase your risk of side effects. If you need to stop taking this medication, your doctor will instruct you on how to gradually discontinue it.

Interactions with Other Substances
Avoid consuming alcohol while taking this medication. Additionally, consult your doctor before using marijuana, other forms of cannabis, or prescription or over-the-counter (OTC) medications that may cause drowsiness.

Delayed Effects
It may take several weeks to experience the full effects of this medication.

Potential Risks
This medication may increase your risk of:

Broken bones: Discuss this risk with your doctor.
Bleeding: This medication may cause bleeding, which can be life-threatening in some cases. Consult your doctor about this risk.
Eye problems: Certain individuals may be more prone to eye issues while taking this medication. Your doctor may recommend an eye exam to assess your risk. If you experience eye pain, changes in vision, or swelling and redness around the eye, contact your doctor immediately.

Low Sodium Levels
This medication can cause low sodium levels, which can be life-threatening and lead to seizures, loss of consciousness, breathing difficulties, or death.

Special Considerations

Older adults (65 and older): Use this medication with caution, as you may be more susceptible to side effects.
Children and adolescents: This medication may affect growth in some cases. Regular growth checks may be necessary. Consult your doctor about this risk.
Fertility: This medication may impact fertility in males, although it is unclear if this effect is reversible.
Pregnancy: Taking this medication during pregnancy may harm the unborn baby. If you become pregnant or are planning to become pregnant, inform your doctor immediately. The risks and benefits of taking this medication during pregnancy will be discussed with you.
+ First trimester: Taking this medication during the first trimester may increase the risk of birth defects (mainly heart defects) in the unborn baby.
+ Third trimester: Taking this medication during the third trimester may increase your risk of bleeding after delivery and may lead to health problems in the newborn.
Breastfeeding: Inform your doctor if you are breastfeeding, as you will need to discuss the potential risks to your baby.
🆘

Overdose Information

Overdose Symptoms:

  • Drowsiness
  • Nausea
  • Vomiting
  • Tachycardia (fast heart rate)
  • Tremor
  • Agitation
  • Dizziness
  • Dilated pupils
  • Serotonin syndrome (severe cases)
  • Seizures
  • Coma

What to Do:

Seek immediate medical attention. Call 911 or your local emergency number. For poison control, call 1-800-222-1222. Treatment is generally supportive and symptomatic. There is no specific antidote.

Drug Interactions

đŸšĢ

Contraindicated Interactions

  • Monoamine Oxidase Inhibitors (MAOIs) - risk of serotonin syndrome
  • Thioridazine - risk of QT prolongation and ventricular arrhythmias
  • Pimozide - risk of QT prolongation and ventricular arrhythmias
🔴

Major Interactions

  • Other serotonergic drugs (e.g., triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, tryptophan, buspirone, St. John's Wort) - increased risk of serotonin syndrome
  • Drugs that prolong the QT interval (e.g., Class IA and III antiarrhythmics, some antipsychotics, macrolide antibiotics) - increased risk of arrhythmias
  • Drugs metabolized by CYP2D6 (e.g., flecainide, propafenone, metoprolol, desipramine, risperidone, atomoxetine) - paroxetine is a potent CYP2D6 inhibitor, leading to increased plasma concentrations of these drugs
  • Warfarin - increased risk of bleeding
  • NSAIDs, aspirin, other antiplatelet agents - increased risk of bleeding
🟡

Moderate Interactions

  • Cimetidine - increases paroxetine plasma levels
  • Phenobarbital, phenytoin - may decrease paroxetine plasma levels
  • Fosamprenavir/ritonavir - may decrease paroxetine plasma levels
  • Tamoxifen - paroxetine may reduce tamoxifen efficacy (due to CYP2D6 inhibition affecting tamoxifen's active metabolite formation)
  • Digoxin - paroxetine may increase digoxin levels
đŸŸĸ

Minor Interactions

  • Alcohol - generally advised to avoid due to CNS depressant effects, though no direct pharmacokinetic interaction.

Monitoring

đŸ”Ŧ

Baseline Monitoring

Psychiatric evaluation (diagnosis, symptom severity)

Rationale: To establish baseline for treatment efficacy and monitor for worsening symptoms or emergence of suicidality.

Timing: Prior to initiation of therapy.

Renal and hepatic function tests (e.g., BUN, creatinine, ALT, AST)

Rationale: To guide initial dosing adjustments in patients with impairment.

Timing: Prior to initiation of therapy.

Electrolytes (especially sodium)

Rationale: To establish baseline, particularly in elderly or those on diuretics, due to risk of hyponatremia.

Timing: Prior to initiation of therapy.

📊

Routine Monitoring

Clinical response and adverse effects

Frequency: Weekly for first 4-6 weeks, then periodically (e.g., monthly or every 3 months) or as clinically indicated.

Target: Symptom improvement, tolerability.

Action Threshold: Lack of efficacy, intolerable side effects, or emergence of new/worsening symptoms (e.g., suicidality, mania) require reassessment and potential dose adjustment or discontinuation.

Suicidality (especially in pediatric, adolescent, and young adult patients)

Frequency: Closely monitor daily during initial weeks of therapy and with dose changes.

Target: Absence of suicidal ideation or behavior.

Action Threshold: Any emergence or worsening of suicidal thoughts or behavior requires immediate clinical intervention.

Weight

Frequency: Periodically (e.g., every 3-6 months).

Target: Stable weight or acceptable changes.

Action Threshold: Significant weight gain or loss may necessitate intervention.

Electrolytes (sodium)

Frequency: Periodically, especially in elderly or those at risk for hyponatremia (e.g., on diuretics).

Target: Normal serum sodium levels (135-145 mEq/L).

Action Threshold: Hyponatremia (<135 mEq/L) requires investigation and management.

đŸ‘ī¸

Symptom Monitoring

  • Worsening depression
  • Emergence of suicidal thoughts or behavior
  • Unusual changes in behavior (e.g., agitation, irritability, anxiety, panic attacks, insomnia, impulsivity, akathisia, hypomania, mania)
  • Symptoms of serotonin syndrome (e.g., agitation, hallucinations, delirium, tachycardia, labile blood pressure, dizziness, diaphoresis, flushing, hyperthermia, tremor, rigidity, myoclonus, hyperreflexia, incoordination, GI symptoms)
  • Symptoms of hyponatremia (e.g., headache, difficulty concentrating, memory impairment, confusion, weakness, unsteadiness, falls, severe and more frequent seizures)
  • Abnormal bleeding or bruising
  • Visual disturbances (e.g., acute angle-closure glaucoma symptoms like eye pain, vision changes, redness/swelling in or around the eye)

Special Patient Groups

🤰

Pregnancy

Paroxetine is classified as Pregnancy Category D. Use should be avoided during pregnancy, especially the first trimester, unless the potential benefit justifies the potential risk to the fetus. Exposure during the first trimester has been associated with an increased risk of cardiovascular malformations (e.g., ventricular septal defects). Exposure in late pregnancy has been associated with persistent pulmonary hypertension of the newborn (PPHN) and neonatal withdrawal syndrome (e.g., respiratory distress, cyanosis, apnea, seizures, temperature instability, feeding difficulty, vomiting, hypoglycemia, hypotonia, hypertonia, hyperreflexia, tremor, jitteriness, irritability, constant crying).

Trimester-Specific Risks:

First Trimester: Increased risk of cardiovascular malformations (e.g., ventricular septal defects).
Second Trimester: Potential for fetal growth restriction; continued risk of PPHN if exposure continues into third trimester.
Third Trimester: Increased risk of persistent pulmonary hypertension of the newborn (PPHN) and neonatal withdrawal syndrome.
🤱

Lactation

Paroxetine is excreted into breast milk. The American Academy of Pediatrics considers paroxetine to be a drug for which the effect on a nursing infant is unknown but may be of concern. Monitor infants for drowsiness, poor feeding, and poor weight gain. Other SSRIs with lower milk transfer (e.g., sertraline) may be preferred.

Infant Risk: L3 (Moderate risk) - detectable levels in breast milk, potential for infant effects (e.g., sedation, irritability, poor feeding), but generally considered compatible with breastfeeding by some experts with careful monitoring.
đŸ‘ļ

Pediatric Use

Paroxetine is generally not recommended for use in pediatric patients for Major Depressive Disorder (MDD) or other psychiatric disorders due to an increased risk of suicidal thinking and behavior (Black Box Warning). It is approved for Obsessive-Compulsive Disorder (OCD) in patients aged 7-17 years, but close monitoring for suicidality is essential.

👴

Geriatric Use

Lower starting doses (e.g., 10 mg/day) are recommended due to reduced clearance and increased susceptibility to adverse effects. Elderly patients are at increased risk for hyponatremia (SIADH), falls, and bleeding. Monitor closely for adverse effects and drug interactions.

Clinical Information

💎

Clinical Pearls

  • Paroxetine is a potent SSRI with a relatively short half-life, which can lead to more pronounced discontinuation symptoms if stopped abruptly. Tapering is crucial.
  • It is a potent inhibitor of CYP2D6, which can lead to significant drug-drug interactions, particularly with other drugs metabolized by this enzyme (e.g., tamoxifen, tricyclic antidepressants, some antipsychotics, beta-blockers).
  • Paroxetine has anticholinergic properties (though less pronounced than TCAs), which may contribute to side effects like constipation, dry mouth, and blurred vision, and may be more problematic in elderly patients.
  • It is one of the more sedating SSRIs, often taken in the morning to avoid insomnia, but some patients may prefer evening dosing if sedation is a significant side effect.
  • Due to its pregnancy category D, it is generally avoided in women of childbearing potential unless other options are not suitable and the benefits clearly outweigh the risks.
  • Weight gain is a common side effect with long-term use of paroxetine compared to other SSRIs.
🔄

Alternative Therapies

  • Other SSRIs (e.g., Sertraline, Fluoxetine, Escitalopram, Citalopram, Fluvoxamine)
  • Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) (e.g., Venlafaxine, Duloxetine, Desvenlafaxine)
  • Atypical Antidepressants (e.g., Bupropion, Mirtazapine, Vortioxetine, Vilazodone)
  • Tricyclic Antidepressants (TCAs) (e.g., Amitriptyline, Nortriptyline, Imipramine)
  • Monoamine Oxidase Inhibitors (MAOIs) (e.g., Phenelzine, Tranylcypromine, Selegiline)
  • Psychotherapy (e.g., Cognitive Behavioral Therapy, Interpersonal Therapy)
💰

Cost & Coverage

Average Cost: $10 - $50 per 30 tablets (generic 20mg)
Generic Available: Yes
Insurance Coverage: Tier 1 or 2 (generic)
📚

General Drug Facts

If your symptoms or health issues persist or worsen, contact your doctor immediately. It is essential to use your prescribed medication responsibly: do not share it with others, and never take someone else's medication. This medication is accompanied by a Medication Guide, which provides crucial information for safe use. Please read this guide carefully and review it each time you receive a refill. If you have any questions or concerns about this medication, consult your doctor, pharmacist, or healthcare provider. In the event of a suspected overdose, promptly call the poison control center or seek immediate medical attention. When reporting the incident, be prepared to provide details about the medication taken, the quantity, and the time it occurred.